Svenska Cellulosa Ab Sca Class A · OMXSTO:SCA_A

Svenska Cellulosa Ab Sca Class A — SCA — FY2012 Earnings Presentation

19 slides from Svenska Cellulosa Ab Sca Class A's earnings presentation, February 2013

  1. Slide 1: SCA Year-end report 2012

    SCA Year-end report 2012 1 January – 31 December 2012

  2. Slide 2: Macro update

    2012 Macro update  Global economy  Weak Western Europe  US showed some growth  China still good growth  Tissue  Strong growth in emerging markets  Some growth in Western Europe and North America  Personal Care  Good demand for incontinence products in Europe  Stable demand for baby diapers

  3. Slide 3: Key events 2012

    Key events 2012  Divestment of the Packaging business, excluding the two kraftliner mills  Acquisition of Georgia-Pacific’s European tissue operations  Strengthened positions in emerging markets  Acquisition of Everbeauty in Asia  Increased shareholding in Vinda  Acquisition of PISA in Chile 

  4. Slide 4: SCA Group's Priorities

    SCA Group’s Priorities EFFICIENCY INNOVATION GROWTH SUSTAINABILITY 4 SCA Year-end report 2012

  5. Slide 5: Efficiency

    Efficiency  2012 Cost and productivity program  Annual cost saving: EUR 300m  Full effect in 2015  Georgia-Pacific synergies  Annual cost saving: EUR 125m  Full effect in 2016  Efficiency program in Forest Products  Annual earnings improvement: SEK 1,300m  Full effect in 2015 5 SCA Year-end

  6. Slide 6: Innovation drives Profitable growth

    Innovation drives Profitable growth Strengthens market positions and profitability 6 SCA Year-end report 2012

  7. Slide 7: Growth

    Growth  Sales growth of 11%*  High growth in emerging markets  Acquisition of Georgia-Pacific´s European tissue operations  Acquisition of Everbeauty, an Asian personal care company  Acquisition of PISA, a Chilean tissue company * 2012 compared with 2011, excluding exchange rate movements and d

  8. Slide 8: Summary: Full year 2012 vs full year 2011

    Summary Full year 2012 vs full year 2011  Sales growth 11%*  Hygiene business, 15%*  Higher volumes  Improved product mix  Acquisitions  Strong growth in emerging markets  Forest Products, -8%*  Lower prices, currency impact  EBIT increased 17%**  Higher volumes  Lower raw material costs

  9. Slide 9: Full year 2012 results

    Full year 2012 results SEK millions Change, Change, unless otherwise stated 2012 2011 % % ** Net sales 85,408 81,337 5 11 EBIT* 8,646 7,738 12 17 EBIT margin* (%) 10.1 9.5 Profit before tax* 7,382 6,413 15 21 Earnings per share (SEK) 7.06 0.78 Operating cash flow 9,644 7,418 30 Debt/Equity ratio 0.5

  10. Slide 10: Summary: Q4 2012 vs Q4 2011

    Summary Q4 2012 vs Q4 2011  Sales growth 21%*  Hygiene business, 25%*  Higher volumes  Acquisitions  Strong growth in emerging markets  Forest Products, -9%*  Lower prices, currency impact  Lower publication paper volumes  EBIT increased 16%**  Higher volumes  Lower raw material costs  A

  11. Slide 11: Q4 2012 results

    Q4 2012 results SEK millions Q4 Q4 Change, Change, unless otherwise stated 2012 2011 Q4/Q4,% Q4/Q4,%** Net sales 23,445 20,935 12 21 EBIT* 2,422 2,139 13 16 EBIT margin* (%) 10.3% 10.2% Profit before tax* 2,129 1,772 20 24 Earnings per share (SEK) 2.97 -4.88 Operating Cash flow 2,446 2,092 17 * Excl

  12. Slide 12: Q4 2012 vs. Q3 2012

    Q4 2012 vs. Q3 2012 Summary  Group  Sales growth 6%  EBIT increased 6%*  Business areas  Personal Care, EBIT increased 4%* • Higher volumes • Lower raw material costs • Improved price/mix  Tissue, EBIT increased 11%* • Lower raw material costs • Higher volumes • Improved price/mix  Forest Pro

  13. Slide 13: Personal Care

    Personal Care Q4 2012 vs Q4 2011  Sales growth 8% (15%*) 7,033 6,529  Incontinence care increased 9%* 8%  Baby diapers increased 17%*  Feminine care increased 11%*  Emerging markets increased 21%* Q4 2012 Q4 2011  EBIT increased 12%** (16%***) 884 792  Higher volumes 12%**  Lower raw materia

  14. Slide 14: Tissue

    Tissue Q4 2012 vs Q4 2011  Sales growth 21% (32%*) 12,460  Consumer tissue increased 38%* 10,280 21%  AFH tissue increased 28%*  Emerging markets increased 23%*  EBIT increased by 36%** (41%***) SALES SEKm Q4 2012 Q4 2011  Higher volumes  Lower raw material costs 1,419  Cost savings 36%**1,0

  15. Slide 15: Forest Products

    Forest Products Q4 2012 vs Q4 2011  Sales decreased 14% (9%*)  Publication papers, decreased sales 4,767 • Lower prices and volumes 4,119 -14%  Solid-wood products, decreased sales • Higher volumes • Lower prices  Kraftliner, flat sales SALES SEKm Q4 2012 Q4 2011  Pulp, flat sales  EBIT decrea

  16. Slide 16: Dividend

    Dividend Proposed 7.1% increase of the dividend to SEK 4.50 (4.20) per share 16 SCA Year-end report 2012

  17. Slide 17: Summary

    Summary  Transformation of SCA  Substantial efficiency programs launched  New hygiene organization  Good sales and earnings growth in the hygiene business  Lower profitability in Forest Products  Strong cash flow generation  Dividend increase 17 SCA Year-end report 2012

  18. Slide 18: Q&A

    Q&A 18 SCA Year-end report 2012

  19. Slide 19: Slide 19

SCA — FY2012 Earnings Presentation on 6ix